Celltrion Healthcare Co.

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

South Korea’s Lotte Wellfood Co. said on Wednesday it partnered with the US YouTuber Topper Guild to promote Pepero  Day.Pepero Day, cele...

Celltrion Inc., South Korea’s largest biosimilar maker, will spend several billion dollars to build a factory to crack the contract developmen...

South Korea’s biosimilar maker Celltrion Inc. will venture into the contract development and manufacturing organization (CDMO) market, the com...

South Korea's Hanwha Systems Co. said on Monday that it signed a mid- to long-term business cooperation memorandum of understanding (MOU) for space ...

Freewheelin, which operates the AI courseware Pulley Campus for university education, said on Friday that it signed an industry-academia cooperation...

Hyundai Department Store Group, a South Korean conglomerate controlling retail, fashion, healthcare and lifestyle businesses, aims to triple its hea...

BGF Retail Co., the operator of South Korea’s leading convenience store chain CU, said on Thursday that it signed a memorandum of understand...

South Korea's cosmetic and clothing company APR said on Wednesday it signed a supply contract with TJX Companies, the North America-based global ret...

South Korea's Kakao Corp. said on August 23 that its mobile solution development subsidiary dK Techin Corp. will merge with its AI technology affili...

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...

South Korea's CHA Healthcare Co., CHA Biotech's overseas medical business affiliate incorporated Singapore's SMG as a subsidiary. CHA Healthcare an...

South Korea’s largest biosimilar maker Celltrion Inc. said on Friday that it has scrapped a plan to merge with Celltrion Pharm Inc., an R&...

South Korea’s job numbers grew in July, led by new hires among those in their 60s and older in one of the world's fastest-aging countries. The...

South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...

Celltrion Inc., South Korea’s biosimilar giant, will proceed with phase 3 trials for global blockbuster drug Keytruda’s copycat CT-P51, ...

Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...

South Korea’s major chemical materials producer Kolon Industries Inc. is set to invest 129.6 billion won ($94.2 million) to establish an indus...

South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...

South Korean semiconductor design house Asicland Co. said on Thursday it signed a $19 million contract with the domestic fabless company FADU.Under ...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...

South Korea's LG Uplus Corp. announced plans to partner with SAMG Entertainment and HighZium Studio Co. to create Korean-style robot content, aimi...

Kolmar Korea, a supplier to global cosmetics brands such as Estee Lauder, announced on Friday that it signed a memorandum of understanding (MOU) wit...

South Korea's aerospace materials company Spear Korea will acquire artificial intelligence (AI) medical firm Life Semantics Co. Life Semantics ...

South Korea’s largest biosimilar maker Celltrion Inc. said on Tuesday that its third plant in Sondgo, west of Seoul, is undergoing process val...

Goldman Sachs Group Inc. said on Monday that it has appointed Ahn Jae-hoon, former managing director at Morgan Stanley & Co. LLC as country co-h...

South Korea's biopharmaceutical company Celltrion Inc. said on Wednesday that its subcutaneous autoimmune disease treatment Remsima SC has surpassed...

South Korea’s luxury goods market, estimated at around $7.1 billion, is experiencing a surge in demand led by affluent consumers in their 40s ...

Samsung C&T Corp., its bio units Samsung Biologics Co. and Samsung Bioepis Co. and Samsung Venture Investment Corp. have committed a combined 72...

South Korea's Daewoong Pharmaceutical Co. announced on Thursday that it signed a contract with Indonesia's Bogor Agricultural University (Institut P...